about
Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so farPomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and ApoptosisEllagitannins in Cancer Chemoprevention and TherapySustained proliferation in cancer: Mechanisms and novel therapeutic targetsTwo UGT84 Family Glycosyltransferases Catalyze a Critical Reaction of Hydrolyzable Tannin Biosynthesis in Pomegranate (Punica granatum)Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme PeroxidasesEffects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signalingResearch progress on the anticarcinogenic actions and mechanisms of ellagic acid.Exploring the Transcriptome Landscape of Pomegranate Fruit Peel for Natural Product Biosynthetic Gene and SSR Marker Discovery(F).Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.Epigenetic modifications by dietary phytochemicals: implications for personalized nutritionMitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.Establishment of pomegranate (Punica granatum) hairy root cultures for genetic interrogation of the hydrolyzable tannin biosynthetic pathway.Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods.Bioactivation of Phytoestrogens: Intestinal Bacteria and Health.Pomegranate extract induces ellagitannin metabolite formation and changes stool microbiota in healthy volunteers.Genome-wide identification of microRNAs in pomegranate (Punica granatum L.) by high-throughput sequencing.Natural products as potential cancer therapy enhancers: A preclinical update.Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway.Chemopreventive potential of natural compounds in head and neck cancerPerspectives for cancer prevention with natural compoundsEllagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor GrowthPlant phytochemicals as epigenetic modulators: role in cancer chemoprevention.Ellagitannin-rich cloudberry inhibits hepatocyte growth factor induced cell migration and phosphatidylinositol 3-kinase/AKT activation in colon carcinoma cells and tumors in Min mice.Chemical composition of polyphenols extracted from strawberry pomace and their effect on physiological properties of diets supplemented with different types of dietary fibre in rats.Plant polyphenols: chemical properties, biological activities, and synthesis.The bioactivity of pomegranate: impact on health and disease.Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer.Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents.Pomegranate and its components as alternative treatment for prostate cancer.Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.Geraniin suppresses tumor cell growth and triggers apoptosis in human glioma via inhibition of STAT3 signaling.Recent Advances in Anticancer Activities and Drug Delivery Systems of Tannins.Effects of ellagic Acid on angiogenic factors in prostate cancer cells.Anticancer Natural Compounds as Epigenetic Modulators of Gene ExpressionPunicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adductsEllagic acid reduces murine schistosomiasis mansoni immunopathology via up-regulation of IL-10 and down-modulation of pro-inflammatory cytokines production.Flavonoids and Ellagitannins Characterization, Antioxidant and Cytotoxic Activities of Phyllanthus acuminatus Vahl.Probiotic Bacteria for Healthier Aging: Immunomodulation and Metabolism of Phytoestrogens.Specificity of Hydrolysable Tannins from Rhus typhina L. to Oxidants in Cell and Cell-Free Models.
P2860
Q21285097-7478ADE6-8D45-4603-818C-BDD10E58D982Q21285102-59A147AE-F7EC-49E9-97F8-B1662B3D29C1Q26748955-D597B4FA-A62F-4C58-A86F-8120ABB4A906Q28396388-B09B5152-447D-447E-BE1D-7A6FDE5A41F4Q28552492-4BA4D33F-7CB8-4F19-A037-5622F29F9BB7Q28552586-A585B0FC-C935-464B-8596-D8A7F1466889Q33774655-E5ABF5C7-1DA7-4140-A7BA-54D4A1E3AC84Q33802503-306A0E46-8227-408C-B511-1E8C0123192CQ34017034-6CB30482-96D5-4F36-880F-A3D8974BAE6EQ34068791-2A38C25B-410F-4D0C-A74A-5339663EEB9FQ34129835-E35BD450-0D9C-4A79-8C00-9B9EEC36B44FQ34243380-B002A05B-7B29-4CDB-98C7-E9BC51358A48Q34343349-4A143DE7-8FBE-4A68-98B4-38CF08B8ADEFQ35104630-5AD14F8F-7643-45F2-8499-253439EDBFA6Q35596030-2BBAB40C-D2ED-4A04-A958-3A1C848DFBF3Q35696757-33E169D7-AEF8-4B27-942F-952B7F8D1CB0Q36031707-998D5830-0B39-419F-ACC0-67215689EBB6Q36165835-A482F56A-0971-4354-85BB-31A2EEEDBE73Q36763380-D023AC81-0766-484B-8FA3-780B73C0B85DQ37097045-5B42B557-67C9-439A-8089-DB2DE424124EQ37212228-3D18C97F-2461-4AB7-8365-6DE9E9ED3876Q37463406-DAF6EDEB-953A-44B3-8670-B09B57F8538AQ37469412-B31C6311-9AD8-44C8-8133-7871A265F88BQ37536730-29CE013F-C59A-4976-B996-121BA364AEBEQ37585962-A9CD5EB2-F185-488F-B7DF-C53B1F7EEDBFQ37827837-98B88A52-E14A-43CC-910C-E25CC7779040Q37906659-4115D3D5-01B4-4881-B5A1-6FC4B0CF7D01Q37962472-14DE08DC-F198-4FC8-998A-3C1A3735F0CCQ38112115-698E5F1A-0CBB-499E-AF30-2A3C237DE6EDQ38243393-61BDB818-6517-4D66-9391-29DA2DB7705CQ38245598-9256A2B5-31E2-4BBA-98A2-3080137F3D5AQ38857150-B3069E4B-3817-48D1-A0DB-313C5A370C2AQ39048429-BBC7AE04-EAD2-4F8B-BE37-F1F49837C354Q39064457-12105B4C-C520-49E5-9A7F-0A7A364636D9Q39214234-9CCE61BD-81AD-45DD-86BE-6F881207045CQ40559873-6BDC75C5-44B0-4E33-9683-5A7B27F696D3Q40653441-C231BFCE-C9FD-4488-B0E3-6CD1926945C4Q46240381-0EAD3159-F028-419A-AA2F-38F196348A9DQ46267327-05762A62-0B27-4341-A138-B78830E0DAAEQ46492831-A2FE7DAF-5D32-4DCC-8ACC-95F238FE7F07
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multitargeted therapy of cancer by ellagitannins.
@en
Multitargeted therapy of cancer by ellagitannins.
@nl
type
label
Multitargeted therapy of cancer by ellagitannins.
@en
Multitargeted therapy of cancer by ellagitannins.
@nl
prefLabel
Multitargeted therapy of cancer by ellagitannins.
@en
Multitargeted therapy of cancer by ellagitannins.
@nl
P1433
P1476
Multitargeted therapy of cancer by ellagitannins.
@en
P2093
David Heber
P304
P356
10.1016/J.CANLET.2008.03.043
P407
P577
2008-05-12T00:00:00Z